Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial
- 1 October 2014
- journal article
- research article
- Published by Elsevier BV in Complementary Therapies in Medicine
- Vol. 22 (5), 851-857
- https://doi.org/10.1016/j.ctim.2014.07.006
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Role of selective peroxisome proliferator‐activated receptor modulators in managing cardiometabolic disease: tale of a roller‐coasterDiabetes, Obesity and Metabolism, 2014
- New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver diseaseExpert Opinion on Pharmacotherapy, 2014
- Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysisCurrent Medical Research and Opinion, 2013
- New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary SyndromesClinical Therapeutics, 2013
- Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic SyndromeCanadian Journal of Diabetes, 2013
- Epidemiology of the metabolic syndrome in the USAJournal of Digestive Diseases, 2011
- Management of Dyslipidemia in the Metabolic SyndromeAmerican Journal of Cardiovascular Drugs, 2007
- Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statinsCardiovascular Diabetology, 2006
- Metabolic Syndrome: The Danger Signal in AtherosclerosisVascular Health and Risk Management, 2006
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)Published by Oxford University Press (OUP) ,2003